Effect of a metal stent on patients with pancreatic cancer
Phase 4
Recruiting
- Conditions
- Pancreatic cancer, obstructive jaundicePancreatic cancer
- Registration Number
- JPRN-jRCT1012200002
- Lead Sponsor
- Kuwatani Masaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Pancreatic cancer patients with jaundice schedul
ed for neoadjuvant chemo-/chemoradiotherapy
Exclusion Criteria
Without jaundice
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biliary event rate until surg ery after stenting
- Secondary Outcome Measures
Name Time Method (1) curative resection rate<br>(2)Time to Recurrent biliary obstruction<br>(3)Chemotherapy accompish/delay/discontinuat<br>ion<br>(4)Other stent-related adverse events<br>(5)Frequency and severity of adverse events after<br>curative surg ery